{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:35:30Z","timestamp":1792193730482,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd013111","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000}}],"reference-count":200,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013111.pub2","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T06:21:52Z","timestamp":1751955712000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer"],"prefix":"10.1002","volume":"2025","author":[{"given":"Maria-Eulalia","family":"Fernandez-Montoli","sequence":"additional","affiliation":[{"name":"Department of Gynecology; Hospital Universitari de Bellvitge, Universitat de Barcelona - IDIBELL. L'Hospitalet de Llobregat; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Sabadell","sequence":"additional","affiliation":[{"name":"Department of Gynecology; Vall d'Hebron Barcelona Hospital Campus, Universitat Aut\u00f2noma de Barcelona; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayanar Adela","family":"Contreras Perez","sequence":"additional","affiliation":[{"name":"Department of Gynecology; Hospital El Pilar Quiron ; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Verdaguer Men\u00e9ndez-Arango","sequence":"additional","affiliation":[{"name":"Department of Gynecology, ASSIR; Matar\u00f3; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Julia Torres","sequence":"additional","affiliation":[{"name":"Department of Gynecology; Hospital de Viladecans, Viladecans; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Lleberia","sequence":"additional","affiliation":[{"name":"Department of Gynecology; Fundaci\u00f3 Hospital de l\u00b4Esperit Sant; Santa Coloma de Gramanet, Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"10.1002\/14651858.CD013111.pub2-BIB0001|cit1","doi-asserted-by":"crossref","unstructured":"Acosta-Torres S Doglioli M Varghese A Tanner EJ Stone RL Levinson KL Efficacy of combined metformin and progestin therapy for complex atypical hyperplasia and well-differentiated endometrial cancer in patients desiring fertility Gynecologic Oncology 2019 267","DOI":"10.1016\/j.ygyno.2019.04.620"},{"issue":"2","key":"10.1002\/14651858.CD013111.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ygyno.2020.02.008","article-title":"The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia\/endometrial intraepithelial neoplasia or endometrial cancer: little impact on response and low live-birth rates","volume":"157","author":"Acosta-Torres","year":"2020","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijgo.2015.06.046","article-title":"Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer","volume":"132","author":"Chen","year":"2016","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0004|cit4","first-page":"403","article-title":"Endometrial hyperplasia. Clinico-pathological considerations of a prospective randomised study after abrasio only or high-dose treatment. Results of 2 years follow-up of 292 patients CNO - CN-00181445","volume":"11","author":"Lindahl","year":"1991","journal-title":"Anticancer Research"},{"issue":"68","key":"10.1002\/14651858.CD013111.pub2-BIB0005|cit5","first-page":"2831","article-title":"Spontaneous endometrial hyperplasia. A 5 year follow-up of 82 patients after high-dose gestagen treatment","volume":"14","author":"Lindahl","year":"1994","journal-title":"Anticancer Research"},{"issue":"5B","key":"10.1002\/14651858.CD013111.pub2-BIB0006|cit6","first-page":"2141","article-title":"Spontaneous endometrial hyperplasia. A prospective, 5 year follow-up of 246 patients after abrasio only, including 380 patients followed-up for 2 years","volume":"14","author":"Lindahl","year":"1994","journal-title":"Anticancer Research"},{"issue":"6","key":"10.1002\/14651858.CD013111.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.3802\/jgo.2019.30.e90","article-title":"Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients","volume":"30","author":"Mitsuhashi","year":"2019","journal-title":"Journal of Gynecologic Oncology"},{"issue":"4","key":"10.1002\/14651858.CD013111.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/1471-0528.12499","article-title":"Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial CNO - CN-00982427","volume":"121","author":"Orbo","year":"2014","journal-title":"BJOG"},{"issue":"4","key":"10.1002\/14651858.CD013111.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ejca.2012.09.017","article-title":"Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)","volume":"49","author":"Park","year":"2013","journal-title":"European Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3802\/jgo.2014.25.3.214","article-title":"Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia C","volume":"25","author":"Shan","year":"2014","journal-title":"Journal of Gynecologic Oncology"},{"issue":"2","key":"10.1002\/14651858.CD013111.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2014.02.020","article-title":"Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin","volume":"133","author":"Simpson","year":"2014","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.3802\/jgo.2023.34.e32","article-title":"Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective, open-label, randomized controlled phase II trial (Clinical trials.gov NCT03241914)","volume":"34","author":"Xu","year":"2023","journal-title":"Journal of Gynecologic Oncology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"A14","DOI":"10.1136\/ijgc-2021-IGCS.26","article-title":"Combined oral megestrol acetate\/ levonorgestrel-intrauterine system for atypical endometrial hyperplasia: a single-center prospective randomized controlled pilot study","volume":"31 Suppl 4","author":"Xu","year":"2021","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ygyno.2023.05.001","article-title":"Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: a prospective, open-label, randomized controlled phase II study","volume":"174","author":"Xu","year":"2023","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0015|cit15","unstructured":"Megestrol acetate plus metformin to megestrol acetate in patients with endometrial atypical hyperplasia or early stage endometrial adenocarcinoma https:\/\/clinicaltrials.gov\/study\/NCT01968317?term=NCT01968317&rank=1"},{"issue":"7","key":"10.1002\/14651858.CD013111.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/1471-0528.16108","article-title":"Metformin plus megestrol acetate compared with MA alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial","volume":"127","author":"Gulinazi","year":"2020","journal-title":"BJOG"},{"issue":"6","key":"10.1002\/14651858.CD013111.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/IGC.0000000000001008","article-title":"Gonadotropin-releasing hormone agonist combined with a levonorgestrel-releasing intrauterine system or letrozole for fertility-preserving treatment of endometrial carcinoma and complex atypical hyperplasia in young women","volume":"27","author":"Zhou","year":"2017","journal-title":"International Journal of Gynecological Cancer"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.tjog.2020.03.014","article-title":"Fertility preservation in early-stage endometrial cancer and endometrial intraepithelial neoplasia: a single-center experience","volume":"59","author":"Ayhan","year":"2020","journal-title":"Taiwanese Journal of Obstetrics & Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD013111.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1158\/1940-6207","article-title":"Weight loss during intrauterine progestin treatment for obesity-associated atypical hyperplasia and early-stage cancer of the endometrium","volume":"14","author":"Barr","year":"2021","journal-title":"Cancer prevention research (Philadelphia, Pa.)"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0020|cit20","first-page":"A311","article-title":"Oncologic and pregnancy outcomes with fertility-sparing management for early endometrial cancer in young women","volume":"29 Suppl 4","author":"Chung","year":"2019","journal-title":"International Journal of Gynecological Cancer"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"801\u20138","DOI":"10.1007\/s00404-019-05059-2","article-title":"Effectiveness of progestin-based therapy for morbidly obese women with complex atypical hyperplasia","volume":"299","author":"Ciccone","year":"2019","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijgo.2012.06.010","article-title":"A Turkish Gynecologic Oncology Group study of fertility-sparing treatment for early-stage endometrial cancer","volume":"119","author":"Dursun","year":"2012","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.3802\/jgo.2017.28.e2","article-title":"Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer","volume":"28","author":"Falcone","year":"2017","journal-title":"Journal of Gynecologic Oncology"},{"issue":"5","key":"10.1002\/14651858.CD013111.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.3802\/jgo.2020.31.e74","article-title":"Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study.","volume":"31","author":"Falcone","year":"2020","journal-title":"Journal of Gynecologic Oncology"},{"issue":"2","key":"10.1002\/14651858.CD013111.pub2-BIB0025|cit25","first-page":"208","article-title":"Efficacy and mechanism of different doses of metformin on early endometrial cancer patients with fertility requirements","volume":"8","author":"Feng","year":"2018","journal-title":"Anti-Tumor Pharmacy"},{"issue":"6","key":"10.1002\/14651858.CD013111.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/AOG.0b013e31828cb563","article-title":"Prediction of regression and relapse of endometrial hyperplasia with conservative therapy","volume":"121","author":"Gallos","year":"2013","journal-title":"Obstetrics and Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD013111.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/humrep\/det320","article-title":"LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study","volume":"28","author":"Gallos","year":"2013","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2021.01.029","article-title":"Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: rresults of a randomized clinical trial","volume":"161","author":"Robledo","year":"2021","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0090-8258(21)00726-5","article-title":"Complete pathological response following levonorgestrel intrauterine device in clinically stage I endometrial adenocarcinoma: results of a randomized clinical trial","volume":"162","author":"Janda","year":"2021","journal-title":"Gynecologic Oncology"},{"issue":"5","key":"10.1002\/14651858.CD013111.pub2-BIB0030|cit30","first-page":"365","article-title":"Treatment for complex atypical hyperplasia of the endometrium","volume":"22","author":"Jobo","year":"2001","journal-title":"European Journal of Gynaecological Oncology"},{"issue":"4","key":"10.1002\/14651858.CD013111.pub2-BIB0031|cit31","first-page":"1320","article-title":"Curative effects of hysteroscopic resection combined with progesterone on early-stage endometrial cancer and its prognosis","volume":"26","author":"Kuang","year":"2021","journal-title":"Journal of BUON"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"255.e1","DOI":"10.1016\/j.ajog.2013.11.001","article-title":"Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma","volume":"210","author":"Kudesia","year":"2014","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2010.10.004","article-title":"Conservative treatment of early endometrial cancer: preliminary results of a pilot study","volume":"120","author":"Laurelli","year":"2011","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.gyobfe.2005.11.005","article-title":"Young women with atypical endometrial hyperplasia or endometrial adenocarcinoma stage I: will conservative treatment allow pregnancy? Results of a French multicentric survey","volume":"34","author":"Le Digabel","year":"2006","journal-title":"Gynecologie, Obstetrique & Fertilite"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.ajog.2019.12.273","article-title":"Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy","volume":"223","author":"Mandelbaum","year":"2020","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD013111.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1089\/jwh.2016.5774","article-title":"Oral progestogens versus levonorgestrel-releasing intrauterine system for treatment of endometrial intraepithelial neoplasia","volume":"26","author":"Marnach","year":"2017","journal-title":"Journal of Women's Health"},{"issue":"9","key":"10.1002\/14651858.CD013111.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/ijgc-2020-001362","article-title":"Route-specific association of progestin therapy and concurrent metformin use in obese women with complex atypical hyperplasia","volume":"30","author":"Matsuo","year":"2020","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0038|cit38","unstructured":"Levonorgestrel-releasing intrauterine system in treating patients with complex atypical hyperplasia or Grade I endometrial cancer https:\/\/clinicaltrials.gov\/study\/NCT00788671"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0039|cit39","unstructured":"The effect of neoadjuvant DMPA on glandular cellularity in women awaiting hysterectomy https:\/\/clinicaltrials.gov\/study\/NCT02335203"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0040|cit40","first-page":"A1\u2013A703","article-title":"Conservative treatment of atypical endometrial hyperplasia and early endometrial cancer: a prospective single institution study of 418 patients","volume":"29 Suppl 4","author":"Novikova","year":"2019","journal-title":"International Journal of Gynecological Cancer"},{"issue":"2","key":"10.1002\/14651858.CD013111.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/jayao.2020.0100","article-title":"Clinical predictive factors of response to treatment in patients undergoing conservative management of atypical endometrial hyperplasia and early endometrial cancer","volume":"10","author":"Raffone","year":"2021","journal-title":"Journal of Adolescent and Young Adult Oncology"},{"issue":"5","key":"10.1002\/14651858.CD013111.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00404-013-2826-8","article-title":"A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women","volume":"288","year":"2013","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"4","key":"10.1002\/14651858.CD013111.pub2-BIB0043|cit43","first-page":"466","article-title":"Fertility-sparing treatment in young women with atypical endometrial hyperplasia and low-grade endometrial cancer: a tertiary center experience","volume":"24","author":"Shikeli","year":"2019","journal-title":"JBRA Assisted Reproduction 2020"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ygyno.2021.03.032","article-title":"Optimal duration of fertility-sparing hormonal treatment for early-stage endometrioid endometrial cancer","volume":"161","author":"Chae","year":"2021","journal-title":"Gynecologic Oncology"},{"issue":"4","key":"10.1002\/14651858.CD013111.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/IGC.0000000000000098","article-title":"Fertility-preserving treatment in young women with endometrial adenocarcinoma: a long-term cohort study","volume":"24","author":"Wang","year":"2014","journal-title":"International Journal of Gynecological Cancer"},{"issue":"4","key":"10.1002\/14651858.CD013111.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/ijgc-2018-000081","article-title":"Impact of treatment duration in fertility-preserving management of endometrial cancer or atypical endometrial hyperplasia","volume":"29","author":"Wang","year":"2019","journal-title":"International Journal of Gynecological Cancer"},{"issue":"8","key":"10.1002\/14651858.CD013111.pub2-BIB0047|cit47","first-page":"1611","article-title":"Administration of cabergoline contributes to preserving fertility in young hyperprolactinemic patients with endometrial cancer treated with medroxyprogesterone acetate","volume":"44","author":"Yamaguchi","year":"2018","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0048|cit48","first-page":"A381","article-title":"The risk factors and therapeutic regimens analyses in the fertility-sparing treatment of refractory endometrial atypical hyperplasia and endometrial cancer","volume":"29 Suppl 4","author":"Yang","year":"2019","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/1961016","article-title":"Metformin in combination with progesterone improves the pregnancy rate for patients with early endometrial cancer","volume":"2022","author":"Yuan","year":"2022","journal-title":"Contrast Media & Molecular Imaging"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.2147\/CMAR.S316040","article-title":"Weight loss improves pregnancy and live birth outcomes in young women with early-stage endometrial cancer and atypical hyperplasia","volume":"14","author":"Zhang","year":"2021","journal-title":"Cancer Management and Research"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0051|cit51","first-page":"1525","article-title":"Efficacy and prognosis of fertility-preserved hysteroscopic surgery combined with progesterone in the treatment of complex endometrial hyperplasia and early endometrial carcinoma","volume":"25","author":"Zonglan","year":"2020","journal-title":"Journal of BUON"},{"issue":"5","key":"10.1002\/14651858.CD013111.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.3802\/jgo.2024.35.e62","article-title":"The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trial","volume":"35","author":"Alnemr","year":"2024","journal-title":"Journal of Gynecologic Oncology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"A45","DOI":"10.1136\/ijgc-2023-IGCS.70","article-title":"The efficacy of metformin in megestrol acetate-based fertility-sparing treatment for patient with endometrial atypical hyperplasia and endometrial cancer: long term outcomes of a randomised controlled trial","volume":"33","author":"Dong","year":"2023","journal-title":"International Journal of Gynecological Cancer"},{"issue":"10","key":"10.1002\/14651858.CD013111.pub2-BIB0054|cit54","first-page":"729","article-title":"The long-term efficacy of metformin in megestrol acetate-based fertility-sparing treatment for patients with endometrial atypical hyperplasia and endometrioid endometrial cancer","volume":"104","author":"Dong","year":"2024","journal-title":"Zhonghua Yi Xue za Zhi [Medical Journal of China]"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"A76","DOI":"10.1136\/ijgc-2023-IGCS.117","article-title":"A multicentre randomised controlled trial on the outcomes of fertility sparing treatment of atypical endometrial hyperplasia","volume":"33","author":"Goh","year":"2023","journal-title":"International Journal of Gynecological Cancer"},{"issue":"9","key":"10.1002\/14651858.CD013111.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1007\/s10815-024-03172-z","article-title":"A multi-centre randomised controlled trial comparing megestrol acetate to levonorgestrel-intrauterine system in fertility sparing treatment of atypical endometrial hyperplasia","volume":"41","author":"Goh","year":"2024","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1186\/s13063-024-08414-0","article-title":"GnRH-a-based fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients: a multicenter, open-label, randomized designed clinical trial protocol","volume":"25","author":"Liu","year":"2024","journal-title":"Trials"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0058|cit58","unstructured":"Primary prevention and uterine preservation in premenopausal women with obesity and endometrial hyperplasia https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05829460"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0059|cit59","unstructured":"A behavioral intervention to promote primary prevention and uterine preservation in premenopausal women with obesity and endometrial hyperplasia https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05903131"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0060|cit60","unstructured":"Progesterone therapeutic regimen plus statins in young women with early endometrial carcinoma and atypical endometrial hyperplasia https:\/\/clinicaltrials.gov\/ct2\/show\/NCT06102863"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"A177","DOI":"10.1136\/ijgc-2023-ESGO.364","article-title":"Fertility sparing treatment in women with complex atypical endometrial hyperplasia- our clinical experience","volume":"33","author":"Papakonstantinou","year":"2023","journal-title":"International Journal of Gynecological Cancer"},{"issue":"11","key":"10.1002\/14651858.CD013111.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.12122\/j.issn.1673-4254.2024.11.01","article-title":"Megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early-stage endometrial adenocarcinoma: a prospective study","volume":"44","author":"Wang","year":"2024","journal-title":"Nan Fang Yi Ke da Xue Xue Bao [Journal of Southern Medical University]"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0063|cit63","unstructured":"Megestrol acetate or levonorgestrel-releasing intrauterine system in treating patients with atypical endometrial hyperplasia or endometrial cancer https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01943058"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0064|cit64","unstructured":"Weight loss referral for healthier survivorship in obese stage I-II endometrial cancer survivors or atypical hyperplasia https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02342730"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0065|cit65","unstructured":"Levonorgestrel-releasing intrauterine system with or without everolimus in treatment patients with atypical hyperplasia or stage IA grade 1 endometrial cancer https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02397083"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0066|cit66","unstructured":"Mirena\u00ae \u00b1 metformin as fertility-preserving treatment for young Asian women with early endometrial cancer https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02990728"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0067|cit67","unstructured":"Exercise and diet intervention in promoting weight loss in obese patients with stage I endometrial cancer https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03042897"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0068|cit68","unstructured":"Value of LNG-IUS as fertility-preserving treatment of EAH and EC https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03463252"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0069|cit69","unstructured":"Bariatric surgery for fertility-sparing treatment of atypical hyperplasia and grade 1 cancer of the endometrium https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04008563"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0070|cit70","unstructured":"Programmed death-1 (PD-1) inhibitor combined with progesterone treatment in endometrial cancer (ECCT) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04046185"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0071|cit71","unstructured":"Fertility sparing management of endometrial cancer and hyperplasia (FETCH) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04362046"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0072|cit72","unstructured":"Megestrol acetate plus rosuvastatin in young women with early endometrial carcinoma https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04491643"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0073|cit73","unstructured":"Megestrol acetate plus rosuvastatin in young women with atypical endometrial hyperplasia https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04491682"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0074|cit74","unstructured":"Metformin plus megestrol acetate as a fertility-sparing treatment in patients with atypical endometrial hyperplasia https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04607252"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0075|cit75","unstructured":"Liraglutide plus megestrol acetate in endometrial atypical hyperplasia https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04683237"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0076|cit76","unstructured":"Levonorgestrel-releasing intrauterine system (LNG-IUS) in the management of atypical endometrial hyperplasia https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04897217"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0077|cit77","unstructured":"Loxenatide plus LNG-IUS in endometrial atypical hyperplasia https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05172999"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0078|cit78","unstructured":"Gonadotropin-releasing hormone agonist (GnRHa) plus letrozole in young women with early endometrial cancer https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05247268"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0079|cit79","unstructured":"A pilot study on fertility conservative treatment of atypical endometrial hyperplasia in Singapore https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05492487"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0080|cit80","unstructured":"Medroxyprogesterone acetate vs LNG-IUS in early-stage endometrioid carcinoma and atypical hyperplasia patients https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05565573"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12978-022-01513-8","article-title":"Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol","volume":"19","author":"Zhao","year":"2022","journal-title":"Reproductive Health"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0082|cit82","unstructured":"Abu-Rustum N Campos SM Arend R Barber E Uterine neoplasms. NCCN clinical practice guidelines in oncology NCCN guidelines. NCCN.org Version 2 (Accessed 1 March 2025) 29439178"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0083|cit83","unstructured":"American Cancer Society Survival by stage of endometrial cancer 2022-2024 https:\/\/www.cancer.org\/cancer\/endometrial-cancer\/detection-diagnosis-staging\/survival-rates.html"},{"issue":"4","key":"10.1002\/14651858.CD013111.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"796\u2013802","DOI":"10.1038\/oby.2008.610","article-title":"Cancer incidence and mortality after gastric bypass surgery","volume":"17","author":"Adams","year":"2009","journal-title":"Obesity (Silver Spring, Md.)"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"124\u20138","DOI":"10.1016\/j.ygyno.2011.12.436","article-title":"Patients with atypical hyperplasia of the endometrium should be treated in oncological centers","volume":"125","author":"Antonsen","year":"2012","journal-title":"Gynecologic Oncology"},{"issue":"2","key":"10.1002\/14651858.CD013111.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ygyno.2017.02.036","article-title":"Long-term incidence of female-specific cancer after bariatric surgery or usual care in the Swedish Obese Subjects Study","volume":"145","author":"Taube","year":"2017","journal-title":"Gynecologic Oncology"},{"issue":"8","key":"10.1002\/14651858.CD013111.pub2-BIB0087|cit87","first-page":"1839","article-title":"Using progestins in clinical practice","volume":"62","author":"Apgar","year":"2000","journal-title":"American Family Physician"},{"issue":"7","key":"10.1002\/14651858.CD013111.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/1471-0528.12100","article-title":"Bariatric surgery and endometrial pathology in asymptomatic morbidly obese women: a prospective, pilot study","volume":"120","author":"Argenta","year":"2013","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygyno.2011.11.043","article-title":"Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature","volume":"125","author":"Baker","year":"2012","journal-title":"Gynecologic Oncology"},{"issue":"4","key":"10.1002\/14651858.CD013111.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2005.02.8464","article-title":"Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study","volume":"24","author":"Barakat","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD013111.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1148\/radiol.11110984","article-title":"Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging","volume":"262","author":"Beddy","year":"2012","journal-title":"Radiology"},{"issue":"5","key":"10.1002\/14651858.CD013111.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jmig.2015.03.017","article-title":"Bariatric surgery: does it play a role in fertility-preserving treatment among obese young women with endometrial cancer?","volume":"22","author":"Benito","year":"2015","journal-title":"Journal of Minimally Invasive Gynecology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ygyno.2019.03.098","article-title":"Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma","volume":"153","author":"Britton","year":"2019","journal-title":"Gynecologic Oncology"},{"issue":"2","key":"10.1002\/14651858.CD013111.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ygyno.2014.06.003","article-title":"Endometrial cancer: a review and current management strategies: part II","volume":"134","author":"Burke","year":"2014","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"67\u201373","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Levine","year":"2013","journal-title":"Nature"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0097|cit97","unstructured":"Cancer Research UK Uterine cancer incidence statistics https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/uterine-cancer#heading-One (2017-2019)"},{"issue":"12","key":"10.1002\/14651858.CD013111.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1136\/ijgc-2021-002699","article-title":"Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis","volume":"31","author":"Chae-Kim","year":"2021","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0099|cit99","unstructured":"Chen LM Berek JS Endometrial carcinoma. Epidemiology and risk factors www.uptodate.com"},{"issue":"2","key":"10.1002\/14651858.CD013111.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jmig.2017.07.022","article-title":"Updates on conservative management of endometrial cancer","volume":"25","author":"Corzo","year":"2018","journal-title":"Journal of Minimally Invasive Gynecology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0101|cit101","unstructured":"Covidence Veritas Health Innovation 2025"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0102|cit102","first-page":"47","article-title":"Carcinoma of the corpus uteri","volume":"6","author":"Creasman","year":"2001","journal-title":"Journal of Epidemiology and Biostatistics"},{"issue":"6","key":"10.1002\/14651858.CD013111.pub2-BIB0103|cit103","first-page":"699\u2013704","article-title":"Endometrial carcinoma in women 40 years of age or younger","volume":"57","author":"Crissman","year":"1981","journal-title":"Obstetrics and Gynecology"},{"issue":"April 9","key":"10.1002\/14651858.CD013111.pub2-BIB0104|cit104","first-page":"1412\u201328","article-title":"Endometrial cancer","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0105|cit105","unstructured":"US Department of Health and Human Services National Institutes of Health National Cancer Institute Common Terminology Criteria For Adverse Events. Version 5.0 https:\/\/ctep.cancer.gov\/...\/electronic...\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf 1 146"},{"issue":"12","key":"10.1002\/14651858.CD013111.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1097\/00000478-200412000-00004","article-title":"Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases","volume":"28","author":"Darvishian","year":"2004","journal-title":"American Journal of Surgical Pathology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejogrb.2022.04.019","article-title":"Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: a systematic review and meta-analysis","volume":"273","author":"De Rocco","year":"2022","journal-title":"European Journal of Obstetrics and Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0108|cit108","unstructured":"Deeks JJ Higgins JP Altman DG McKenzie JE Veroniki AA Chapter 10: Analysing data and undertaking meta-analyses (last updated November 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00004347-199907000-00008","article-title":"Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis","volume":"18","author":"Demopoulos","year":"1999","journal-title":"International Journal of Gynecological Pathology"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"2","key":"10.1002\/14651858.CD013111.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ygyno.2005.06.010","article-title":"Surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy shows well-differentiated tumors","volume":"99","author":"Eltabbakh","year":"2005","journal-title":"Gynecologic Oncology"},{"issue":"7","key":"10.1002\/14651858.CD013111.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/IGC.0b013e3181e94f5a","article-title":"Fertility-sparing therapy in young women with endometrial cancer: 2010 update","volume":"20","author":"Erkanli","year":"2010","journal-title":"International Journal of Gynecological Cancer"},{"issue":"2","key":"10.1002\/14651858.CD013111.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/IGC.0000000000001164","article-title":"Fertility-preserving treatment in young women with Grade 1 presumed stage IA endometrial adenocarcinoma meta-analysis","volume":"28","author":"Fan","year":"2018","journal-title":"International Journal of Gynecological Cancer"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"391\u2013401","DOI":"10.1530\/ERC-12-0333","article-title":"Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer","volume":"20","author":"Ferguson","year":"2013","journal-title":"Endocrine-related Cancer"},{"issue":"6","key":"10.1002\/14651858.CD013111.pub2-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ajog.2010.07.037","article-title":"Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis","volume":"203","author":"Gallos","year":"2010","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD013111.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"266.e1","DOI":"10.1016\/j.ajog.2012.08.011","article-title":"Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis","volume":"207","author":"Gallos","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD013111.pub2-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jmig.2018.07.001","article-title":"Hysteroscopic endometrial focal resection followed by levonorgestrel intrauterine device insertion as a fertility sparing treatment of atypical endometrial hyperplasia and early endometrial cancer. A retrospective study","volume":"26","author":"Giampaolino","year":"2019","journal-title":"Journal of Minimally Invasive Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2014.11.012","article-title":"Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study","volume":"136","author":"Gottschau","year":"2015","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0119|cit119","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2015"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ijgo.12882","article-title":"A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma","volume":"146","author":"Guillon","year":"2019","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD013111.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecologic Oncology"},{"issue":"7414","key":"10.1002\/14651858.CD013111.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0123|cit123","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017. Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v5.2.0"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0124|cit124","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect (last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jclinepi.2017.05.006","article-title":"The GRADE Working Group clarifies the construct of certainty of evidence","volume":"87","author":"Hultcrantz","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD013111.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.puhe.2015.04.017","article-title":"The effect of body mass index on endometrial cancer: a meta-analysis","volume":"129","author":"Jenabi","year":"2015","journal-title":"Public Health"},{"issue":"4","key":"10.1002\/14651858.CD013111.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/09513590.2017.1395841","article-title":"Treatment strategies for women with polycystic ovary syndrome","volume":"34","author":"Jin","year":"2018","journal-title":"Gynecological Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD013111.pub2-BIB0128|cit128","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3892\/ol.2023.13754","article-title":"Risk of endometrial cancer in patients with polycystic ovarian syndrome: a meta.analysis","volume":"25","author":"Daley","year":"2023","journal-title":"Oncology Letters"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cacc.2009.10.005","article-title":"Bariatric surgery: techniques, outcomes and complications","volume":"21","author":"Khwaja","year":"2010","journal-title":"Current Anaesthesia and Critical Care"},{"issue":"2","key":"10.1002\/14651858.CD013111.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5468\/OGS.2013.56.2.67","article-title":"Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases","volume":"56","author":"Kim","year":"2013","journal-title":"Obstetrics & Gynecology Science"},{"issue":"6","key":"10.1002\/14651858.CD013111.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00330-008-1271-8","article-title":"Accuracy of integrated FDG-PET\/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer","volume":"19","author":"Kitajima","year":"2009","journal-title":"European Radiology"},{"issue":"2","key":"10.1002\/14651858.CD013111.pub2-BIB0132|cit132","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012513.pub2","article-title":"Interventions for weight reduction in obesity to improve survival in women with endometrial cancer","author":"Kitson","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.fertnstert.2013.11.028","article-title":"Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic reviewand meta-analysis","volume":"101","author":"Koskas","year":"2014","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD013111.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long term study of \"untreated\" hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/978-1-4757-1942-0_11","volume-title":"Blaustein's Pathology of the Female Genital Tract","author":"Kurman","year":"1987"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0136|cit136","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4419-0489-8","volume-title":"Blaustein's Pathology of the Female Genital Tract","volume":"1","author":"Kurman","year":"2011"},{"issue":"5","key":"10.1002\/14651858.CD013111.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1200\/JCO.2009.24.1315","article-title":"Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia","volume":"28","author":"Lacey","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"10.1002\/14651858.CD013111.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"976\u201382","DOI":"10.1111\/j.1600-0412.2012.01438.x","article-title":"Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey","volume":"91","author":"Lajer","year":"2012","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/2046-4053-2-81","article-title":"Assessing and presenting summaries of evidence in Cochrane Reviews","volume":"2","author":"Langendam","year":"2013","journal-title":"Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/01.AOG.0000255980.88205.15","article-title":"Prognostic factors for uterine cancer in reproductive-aged women","volume":"109","author":"Lee","year":"2007","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ygyno.2008.12.017","article-title":"Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma","volume":"113","author":"Kehoe","year":"2009","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ygyno.2017.07.144","article-title":"Changes in inflammatory endometrial cancer risk biomarkers in individuals undergoing surgical weight loss","volume":"147","author":"Linkov","year":"2017","journal-title":"Gynecologic Oncology"},{"issue":"11","key":"10.1002\/14651858.CD013111.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1200\/JCO.2016.70.5822","article-title":"Intentional weight loss and endometrial cancer risk","volume":"35","author":"Luo","year":"2017","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"10.1002\/14651858.CD013111.pub2-BIB0144|cit144","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009458","article-title":"Oral and intrauterine progestogens for atypical endometrial hyperplasia","author":"Luo","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD013111.pub2-BIB0145|cit145","first-page":"791\u20134","article-title":"Obesity-driven endometrial cancer: is weight loss the answer?","volume":"120","author":"Mackintosh","year":"2013","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41572-021-00324-8","article-title":"Endometrial cancer","volume":"7","author":"Makker","year":"2022","journal-title":"Nature Reviews. Disease Primers"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5152\/jtgga.2013.69379","article-title":"Two cases of successful pregnancies after hysteroscopic removal of endometrioid adenocarcinoma grade I, stage IA, in young women with Lynch syndrome","volume":"15","author":"Marton","year":"2014","journal-title":"Journal of the Turkish German Gynecological Association"},{"issue":"5","key":"10.1002\/14651858.CD013111.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/ijgc-00009577-200509000-00041","article-title":"Reproductive preservation for treatment of stage IA endometrial cancer in a young woman: hysteroscopic resection","volume":"15","author":"Mazzon","year":"2005","journal-title":"International Journal of Gynecological Cancer"},{"issue":"4","key":"10.1002\/14651858.CD013111.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.fertnstert.2008.12.009","article-title":"Conservative surgical management of stage IA endometrial carcinoma for fertility preservation","volume":"93","author":"Mazzon","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0150|cit150","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods (last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook."},{"key":"10.1002\/14651858.CD013111.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/2046-4053-3-82","article-title":"A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation","volume":"3","author":"Meader","year":"2014","journal-title":"Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ygyno.2017.07.120","article-title":"Effects of metformin on endometrial cancer: systematic review and meta-analysis","volume":"147","author":"Meireles","year":"2017","journal-title":"Gynecologic Oncology"},{"issue":"9","key":"10.1002\/14651858.CD013111.pub2-BIB0153|cit153","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012658.pub2","article-title":"Levonorgestrel-releasing intrauterine system for endometrial hyperplasia","author":"Mittermeier","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jsbmb.2004.07.007","article-title":"Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma","volume":"92","author":"Miyamoto","year":"2004","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"2","key":"10.1002\/14651858.CD013111.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ygyno.2015.05.015","article-title":"Women at extreme risk for obesity-related carcinogenesis: baseline endometrial pathology and impact of bariatric surgery on weight, metabolic profiles and quality of life","volume":"138","author":"Modesitt","year":"2015","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0157|cit157","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ejogrb.2021.11.423","article-title":"British Gynaecological Cancer Society (BGCS) uterine cancer guidelines: recommendations for practice","volume":"270","author":"Morrison","year":"2022","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ygyno.2009.05.038","article-title":"Young patients with endometrial cancer: how many could be eligible for fertility-sparing treatment?","volume":"114","author":"Navarria","year":"2009","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02490129","article-title":"Conservative therapy for endometrial carcinoma in young women treated with repeated curettage and progestogen","volume":"2","author":"Niwa","year":"1997","journal-title":"International Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD013111.pub2-BIB0160|cit160","doi-asserted-by":"publisher","first-page":"417","DOI":"10.5468\/ogs.19169","article-title":"Fertility-sparing treatment in early endometrial cancer:current state and future strategies","volume":"63","author":"Obermair","year":"2020","journal-title":"Obstetrics & Gynecology Science"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"284\u201392","DOI":"10.1111\/his.12249","article-title":"Reproducibility of current classifications ofendometrial endometrioid glandular proliferations: further evidence supporting a simplified classification","volume":"64","author":"Ordi","year":"2014","journal-title":"Histopathology"},{"issue":"24","key":"10.1002\/14651858.CD013111.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"11","key":"10.1002\/14651858.CD013111.pub2-BIB0163|cit163","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/jnci\/djy040","article-title":"The effects of metformin and weight loss on biomarkers associated with breast cancer outcomes","volume":"110","author":"Patterson","year":"2018","journal-title":"Journal of the National Cancer Institute"},{"issue":"2","key":"10.1002\/14651858.CD013111.pub2-BIB0164|cit164","first-page":"103\u20134","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0165|cit165","unstructured":"Plaxe SC Mundt AJ Treatment of low-risk endometrial cancer www.uptodate.com"},{"issue":"11","key":"10.1002\/14651858.CD013111.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/PAS.0b013e31825dd4ff","article-title":"Clinical outcome of atypical endometrial hyperplasia diagnosed on an endometrial biopsy: institutional experience and review of literature","volume":"36","author":"Rakha","year":"2012","journal-title":"American Journal of Surgical Pathology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0167|cit167","unstructured":"Gallos ID Alazzam M Clark TJ Faraj R Rosenthal AN Smith PP Management of endometrial hyperplasia. Royal College of Obstetricians & Gynaecologists\/British Society for Gynaecologic Endoscopy (RCOG\/BSGE). Green top guideline No.67 www.rcog.org.uk\/en\/guidelines-research-services\/guidelines\/gtg67\/"},{"issue":"6","key":"10.1002\/14651858.CD013111.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"678.e1","DOI":"10.1016\/j.ajog.2009.02.032","article-title":"Incidence of endometrial hyperplasia","volume":"200","author":"Reed","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0169|cit169","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2025"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.clbc.2012.12.002","article-title":"Favorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obese","volume":"13","author":"Rock","year":"2013","journal-title":"Clinical Breast Cancer"},{"issue":"7","key":"10.1002\/14651858.CD013111.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/IGC.0000000000000493","article-title":"European Society of Gynecological Oncology task force for fertility preservation: clinical recommendations for fertility-sparing management in young endometrial cancer patients","volume":"25","author":"Rodolakis","year":"2015","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0172|cit172","doi-asserted-by":"publisher","first-page":"hoac057","DOI":"10.1093\/hropen\/hoac057","article-title":"ESGO\/ESHRE\/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma","volume":"1","author":"Rodolakis","year":"2023","journal-title":"Human Reproduction Open"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0173|cit173","unstructured":"Ryan R Hills S How to GRADE the quality of the evidence Version 3.0 Cochrane Consumers and Communication Group, available at http:\/\/cccrg.cochrane.org\/author-resources 2016"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0174|cit174","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence (last updated May 2025). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5.1. Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ygyno.2015.10.020","article-title":"Body mass index and mortality in endometrial cancer: a systematic review and meta-analysis","volume":"140","author":"Secord","year":"2016","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0176|cit176","unstructured":"National Cancer Institute: Surveillance and End Results Program Uterine Cancer Uterine Cancer. National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/statfacts\/html\/corp.html"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6874-8-8","article-title":"A systematic review of tests for lymph node status in primary endometrial cancer","volume":"8","author":"Selman","year":"2008","journal-title":"BMC Women's Health"},{"issue":"5","key":"10.1002\/14651858.CD013111.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/09513590312331290298","article-title":"Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent","volume":"17","author":"Session","year":"2003","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0179|cit179","doi-asserted-by":"publisher","first-page":"1115\u201323","DOI":"10.1007\/s00404-013-2826-8","article-title":"A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women","volume":"288","author":"Shan","year":"2013","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"606\u201310","DOI":"10.1016\/j.ygyno.2014.01.004","article-title":"Hyperinsulinemia is associated with endometrial hyperplasia and disordered proliferative endometrium: a prospective cross- sectional study","volume":"132","author":"Shan","year":"2014","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0181|cit181","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-20185-6","volume-title":"Handbook of Contraception: A Guide for Practical Management (Current Clinical Practice)","author":"Shoupe","year":"2016"},{"issue":"1","key":"10.1002\/14651858.CD013111.pub2-BIB0182|cit182","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0183|cit183","first-page":"7\u201333","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"3","key":"10.1002\/14651858.CD013111.pub2-BIB0184|cit184","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010931.pub2","article-title":"Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility","author":"Skalkidou","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejogrb.2017.04.015","article-title":"BGCS uterine cancer guidelines: recommendations for practice","volume":"213","author":"Sundar","year":"2017","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0187|cit187","first-page":"209\u201349","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: a Cancer Journal for Clinicians"},{"issue":"23","key":"10.1002\/14651858.CD013111.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"10067\u201370","DOI":"10.7314\/APJCP.2014.15.23.10067","article-title":"Antiproliferative effect of metformin on the endometrium-a clinical trial","volume":"15","author":"Tabrizi","year":"2015","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0189|cit189","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of promise: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"issue":"4","key":"10.1002\/14651858.CD013111.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"949\u201355","DOI":"10.1016\/j.soard.2014.09.024","article-title":"Bariatric surgery and risk of postoperative endometrial cancer: a systematic review and meta-analysis","volume":"11","author":"Upala","year":"2015","journal-title":"Surgery for Obesity and Related Diseases"},{"issue":"19","key":"10.1002\/14651858.CD013111.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD013111.pub2-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"223\u201331","DOI":"10.1016\/j.canlet.2012.03.026","article-title":"Insulin promotes proliferation, survival, and invasion in endometrial carcinoma by activating the MEK\/ERK pathway","volume":"322","author":"Wang","year":"2012","journal-title":"Cancer Letters"},{"issue":"37","key":"10.1002\/14651858.CD013111.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"e8034","DOI":"10.1097\/MD.0000000000008034","article-title":"Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: a meta-analysis and systematic review","volume":"96","author":"Wei","year":"2017","journal-title":"Medicine"},{"issue":"5","key":"10.1002\/14651858.CD013111.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s11695-018-3151-x","article-title":"Does bariatric surgery affect the incidence of endometrial cancer development? A systematic review","volume":"28","author":"Winder","year":"2018","journal-title":"Obesity Surgery"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"14243","DOI":"10.1038\/srep14243","article-title":"Parity and endometrial cancer risk: a meta-analysis of epidemiological studies","volume":"5","author":"Wu","year":"2015","journal-title":"Scientific Reports"},{"issue":"3-5","key":"10.1002\/14651858.CD013111.pub2-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"113\u201320","DOI":"10.1016\/j.jsbmb.2010.12.006","article-title":"Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells","volume":"126","author":"Xie","year":"2011","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"5","key":"10.1002\/14651858.CD013111.pub2-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/bjc.2015.24","article-title":"Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2)","volume":"112","author":"Yang","year":"2015","journal-title":"British Journal of Cancer"},{"issue":"15 Suppl","key":"10.1002\/14651858.CD013111.pub2-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1200\/JCO.2017.35.15_suppl.1551","article-title":"Prospective randomized biomarker study of metformin and lifestyle intervention for prevention in obese postmenopausal women at increased risk for endometrial cancer","volume":"35","author":"Yates","year":"2017","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD013111.pub2-BIB0199|cit199","first-page":"125\u20136","volume-title":"WHO Classification of Tumours of Female Reproductive Organs","author":"Zaino","year":"2014"},{"issue":"8","key":"10.1002\/14651858.CD013111.pub2-BIB0200|cit200","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013111","article-title":"Fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer","author":"Fernandez-Montoli","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T19:51:29Z","timestamp":1774554689000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013111.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":200,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013111.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]}}}